Cipher Pharmaceuticals

Cipher Pharmaceuticals EBITDA per Share

The EBITDA per Share of Cipher Pharmaceuticals (CPH.TO) as of Nov 4, 2026 is 0.65 USD. In the previous year, EBITDA per Share was 0.48 USD — a change of 33.80% (higher).

EBITDA per Share

0.65USD

YoY

33.80%

Last updated:

EBITDA per Share of Cipher Pharmaceuticals is 2025 0.65 USD. EBITDA per Share of Cipher Pharmaceuticals was 2024 0.48 USD. It decreases by 33.80% higher compared to the previous year.

The Cipher Pharmaceuticals EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.20 USD
Jan 1, 2019
0.43 USD
Jan 1, 2020
0.45 USD
Jan 1, 2021
0.44 USD
Jan 1, 2022
0.51 USD
Jan 1, 2023
0.50 USD
Jan 1, 2024
0.48 USD
Jan 1, 2025
0.65 USD
The Cipher Pharmaceuticals EBITDA per Share history
YEAREBITDA per ShareYoY
0.65USD+33.80%
0.48USD-3.40%
0.50USD-1.83%
0.51USD+15.58%
0.44USD-2.28%
0.45USD+4.41%
0.43USD+112.00%
0.20USD-78.29%
0.94USD+260.27%
0.26USD-10,460.29%
-0.00USD-98.36%
-0.15USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cipher Pharmaceuticals Stock analysis

What does Cipher Pharmaceuticals do? Cipher Pharmaceuticals Inc. is a Canadian pharmaceutical company specializing in the development, marketing, and distribution of medications. The company was founded in 1999 and is headquartered in Oakville, Ontario, Canada. Translator note: The translation provided above is a faithful rendering of the German text into English. Cipher Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cipher Pharmaceuticals stock

EBITDA per Share of Cipher Pharmaceuticals is 0.65 USD in 2025.

EBITDA per Share of Cipher Pharmaceuticals changed from 0.48 USD to 0.65 USD, representing a 33.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Cipher Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Cipher Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Cipher Pharmaceuticals